Octagon Capital Advisors LP Gossamer Bio, Inc. Call Options Transaction History
Octagon Capital Advisors LP
- $263 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GOSS
# of Institutions
147Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Nea Management Company, LLC Timonium, MD18.1MShares$43.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$27.6 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$19.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$17.3 Million0.02% of portfolio
-
683 Capital Management, LLC New York, NY6.34MShares$15.3 Million0.61% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $227M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...